Kimberly Cornelison
Primary Care · Birmingham, ALNPI 1154715662
Payments from drug & device makers
Across 41 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$175
- Neurocrine Biosciences, Inc.$120
- Alkermes, Inc.$119
- Otsuka America Pharmaceutical, Inc.$70
- Lundbeck LLC$60
- Medtronic$58
- plus $166 from 7 others
What the payments were for
- Food & beverage$768100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $175 |
| Neurocrine Biosciences, Inc. | 5 | $120 |
| Alkermes, Inc. | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Lundbeck LLC | 3 | $60 |
| Medtronic | 3 | $58 |
| GSK | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Abbott | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| AbbVie | 1 | $20 |
| Amgen | 1 | $13 |
How this compares
$768 in reported general payments places this provider in the 50th percentile of 159 primary care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $443 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $361 |
| Methylprednisolone | 20 | $198 |
| Azithromycin | 20 | $119 |
| Fluticasone Propionate | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Other primary care in Birmingham
- Samantha WilliamsBirmingham$18K
- Josh WarrenBirmingham$9K
- Jill AroraBirmingham$6K
- Bevin EllenbergBirmingham$5K
- Barbara BoreenBirmingham$4K
- Joanna ReavesBirmingham$3K
- Anna MesserBirmingham$2K
- Hannah WuisanBirmingham$2K
- Tiffany LasernaBirmingham$2K
- Holly StraussBirmingham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.